PP
Paloma Partners Portfolio holdings
AUM
$441M
1-Year Return
4.47%
This Quarter Return
+2.21%
1 Year Return
+4.47%
3 Year Return
+8.76%
5 Year Return
+38.26%
10 Year Return
+97.98%
AUM
$3B
AUM Growth
-$184M
(-5.8%)
Cap. Flow
-$701M
Cap. Flow
% of AUM
-23.37%
Top 10 Holdings %
Top 10 Hldgs %
19.99%
Holding
1,845
New
359
Increased
370
Reduced
469
Closed
595
Top Buys
| 1 |
CBRE Group
CBRE
|
+$31.9M |
| 2 |
Weyerhaeuser
WY
|
+$29.7M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$29.6M |
| 4 |
Crown Castle
CCI
|
+$29.6M |
| 5 |
American Tower
AMT
|
+$29M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$71.7M |
| 2 |
ALR
Alere Inc
ALR
|
+$37.9M |
| 3 |
PRXL
Parexel International Corp
PRXL
|
+$25.5M |
| 4 |
Civitas Resources
CIVI
|
+$23.3M |
| 5 |
Utilities Select Sector SPDR Fund
XLU
|
+$22M |
Sector Composition
| 1 | Financials | 10.32% |
| 2 | Technology | 10.04% |
| 3 | Real Estate | 9.58% |
| 4 | Consumer Discretionary | 7.56% |
| 5 | Industrials | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Markel Group
MKL
$24.3B
| $230K | ﹤0.01% |
202
-463
| -70% | -$527K |
|
1052
NorthWestern Energy
NWE
$3.47B
| $230K | ﹤0.01% |
3,849
-2,205
| -36% | -$132K |
|
|
JNCE
1053
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $230K | ﹤0.01% |
+18,007
| New | +$230K |
|
1054
Kohl's
KSS
$1.8B
| $229K | ﹤0.01% |
+4,225
| New | +$229K |
|
|
NEWR
1055
DELISTED
New Relic, Inc.
NEWR
| $229K | ﹤0.01% |
3,955
-888
| -18% | -$51.4K |
|
1056
ATN International
ATNI
$235M
| $228K | ﹤0.01% |
+4,115
| New | +$228K |
|
1057
Thor Industries
THO
$5.83B
| $228K | ﹤0.01% |
1,514
-23,806
| -94% | -$3.59M |
|
|
FNTEW
1058
DELISTED
FinTech Acquisition Corp. II Warrant
FNTEW
| $228K | ﹤0.01% |
185,000
-2,500
| -1% | -$3.08K |
|
|
TCF
1059
DELISTED
TCF Financial Corporation
TCF
| $228K | ﹤0.01% |
11,142
-19,999
| -64% | -$409K |
|
1060
Commerce Bancshares
CBSH
$8B
| $227K | ﹤0.01% |
5,713
-15,664
| -73% | -$622K |
|
1061
Calavo Growers
CVGW
$479M
| $227K | ﹤0.01% |
+2,694
| New | +$227K |
|
1062
Liberty Broadband Class A
LBRDA
$8.61B
| $227K | ﹤0.01% |
+2,669
| New | +$227K |
|
1063
Trade Desk
TTD
$22.1B
| $227K | ﹤0.01% |
+49,640
| New | +$227K |
|
|
MACK
1064
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $227K | ﹤0.01% |
+28,160
| New | +$227K |
|
1065
Algonquin Power & Utilities
AQN
$4.3B
| $227K | ﹤0.01% |
+20,317
| New | +$227K |
|
1066
Builders FirstSource
BLDR
$16.2B
| $226K | ﹤0.01% |
+10,389
| New | +$226K |
|
1067
Cannae Holdings
CNNE
$1.1B
| $225K | ﹤0.01% |
+13,231
| New | +$225K |
|
|
EQC
1068
DELISTED
Equity Commonwealth
EQC
| $225K | ﹤0.01% |
7,374
-9,211
| -56% | -$281K |
|
1069
Inogen
INGN
$225M
| $224K | ﹤0.01% |
1,887
-13,908
| -88% | -$1.65M |
|
1070
Robert Half
RHI
$3.56B
| $224K | ﹤0.01% |
4,028
-3,531
| -47% | -$196K |
|
|
MDRX
1071
DELISTED
Veradigm Inc. Common Stock
MDRX
| $224K | ﹤0.01% |
15,390
-60,912
| -80% | -$887K |
|
1072
Idacorp
IDA
$6.76B
| $223K | ﹤0.01% |
2,440
-4,115
| -63% | -$376K |
|
|
ALDR
1073
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $222K | ﹤0.01% |
+19,411
| New | +$222K |
|
1074
Cemex
CX
$13.3B
| $220K | ﹤0.01% |
+29,365
| New | +$220K |
|
1075
Emcor
EME
$28.4B
| $220K | ﹤0.01% |
2,692
-4,574
| -63% | -$374K |
|